domains / families / science / liquid-biopsy-analytics-agent
liquid-biopsy-analytics-agent
separate
Comprehensive analysis of liquid biopsy data (ctDNA, CTCs) for cancer detection, MRD monitoring, and response tracking.
When to use
- For multi-cancer early detection screening from blood samples.
- To monitor minimal residual disease (MRD) after curative treatment.
- When tracking tumor evolution and resistance during therapy.
- For real-time treatment response assessment.
- To detect cancer recurrence before clinical or imaging evidence.
When not to use
- detailed ctDNA workflows
- evolutionary analysis
- residual disease focus
Skill page
Source